Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 10, Number 12, 1 December 2012

Free Content Final message from the current Editors in Chief
pp. 2417-2417(1)
Authors: GREAVES, M.; LANE, D. A.

Favourites:
ADD

Free Content The future of glycoprotein VI as an antithrombotic target
pp. 2418-2427(10)
Authors: ZAHID, M.; MANGIN, P.; LOYAU, S.; HECHLER, B.; BILLIALD, P.; GACHET, C.; JANDROT‐PERRUS, M.

Favourites:
ADD

Free Content von Willebrand factor: the old, the new and the unknown
pp. 2428-2437(10)
Authors: LENTING, P. J.; CASARI, C.; CHRISTOPHE, O. D.; DENIS, C. V.

Favourites:
ADD

Free Content Air pollution, vascular disease and thrombosis: linking clinical data and pathogenic mechanisms
pp. 2438-2451(14)
Authors: FRANCHINI, M.; GUIDA, A.; TUFANO, A.; COPPOLA, A.

Favourites:
ADD

Free Content Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention
pp. 2452-2461(10)
Authors: MANGIACAPRA, F.; BARTUNEK, J.; BIJNENS, N.; PEACE, A. J.; DIERICKX, K.; BAILLEUL, E.; DI SERAFINO, L.; PYXARAS, S. A.; FRAEYMAN, A.; MEEUS, P.; RUTTEN, M.; DE BRUYNE, B.; WIJNS, W.; VAN de VOSSE, F.; BARBATO, E.

Favourites:
ADD

Free Content Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk
pp. 2462-2469(8)
Authors: OLSON, M. T.; KICKLER, T. S.; LAWSON, J. A.; MCLEAN, R. C.; JANI, J.; FITZGERALD, G. A.; RADE, J. J.

Favourites:
ADD

Free Content Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis
pp. 2470-2480(11)
Authors: BECKER, E.M.; PERZBORN, E.; KLIPP, A.; LÜCKER, C.; BÜTEHORN, U.; KAST, R.; BADIMON, J. J.; LAUX, V.

Favourites:
ADD
Favourites:
ADD

Free Content Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients
pp. 2484-2493(10)
Authors: OCAK, G.; VAN STRALEN, K. J.; ROSENDAAL, F. R.; VERDUIJN, M.; RAVANI, P.; PALSSON, R.; LEIVESTAD, T.; HOITSMA, A. J.; FERRER‐ALAMAR, M.; FINNE, P.; DE MEESTER, J.; WANNER, C.; DEKKER, F. W.; JAGER, K. J.

Favourites:
ADD

Free Content Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada
pp. 2494-2502(9)
Authors: KRAFT, J.; BLANCHETTE, V.; BABYN, P.; FELDMAN, B.; CLOUTIER, S.; ISRAELS, S.; PAI, M.; RIVARD, G.‐E.; GOMER, S.; McLIMONT, M.; MOINEDDIN, R.; DORIA, A. S.

Favourites:
ADD

Free Content Origin of Swedish hemophilia A mutations
pp. 2503-2511(9)
Authors: HALLDÉN, C.; NILSSON, D.; SÄLL, T.; LIND‐HALLDÉN, C.; LIDÉN, A. C.; LJUNG, R.

Favourites:
ADD

Free Content Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities
pp. 2512-2518(7)
Authors: SCIASCIA, S.; MURRU, V.; SANNA, G.; ROCCATELLO, D.; KHAMASHTA, M. A.; BERTOLACCINI, M. L.

Favourites:
ADD

Free Content Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels
pp. 2519-2525(7)
Authors: ROACH, R. E. J.; SIEGERINK, B.; le CESSIE, S.; ROSENDAAL, F. R.; CANNEGIETER, S. C.; LIJFERING, W. M.

Favourites:
ADD

Free Content Women’s views on and adherence to low‐molecular‐weight heparin therapy during pregnancy and the puerperium
pp. 2526-2534(9)
Authors: PATEL, J. P.; AUYEUNG, V.; PATEL, R. K.; MARSH, M. S.; GREEN, B.; ARYA, R.; DAVIES, J. G.

Favourites:
ADD

Free Content VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity
pp. 2535-2543(9)
Authors: HODROGE, A.; MATAGRIN, B.; MOREAU, C.; FOUREL, I.; HAMMED, A.; BENOIT, E.; LATTARD, V.

Favourites:
ADD

Free Content Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method
pp. 2544-2554(11)
Authors: LOEFFEN, R.; KLEINEGRIS, M.‐C. F.; LOUBELE, S. T. B. G.; PLUIJMEN, P. H. M.; FENS, D.; van OERLE, R.; ten CATE, H.; SPRONK, H. M. H.

Favourites:
ADD

Free Content The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency
pp. 2555-2562(8)
Authors: VERCAUTEREN, E.; PEETERS, M.; HOYLAERTS, M. F.; LIJNEN, H. R.; MEIJERS, J. C. M.; DECLERCK, P. J.; GILS, A.

Favourites:
ADD

Free Content Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP‐induced platelet activation
pp. 2573-2580(8)
Authors: CHANG, H.; YANACHKOV, I. B.; DIX, E. J.; LI, Y. F.; BARNARD, M. R.; WRIGHT, G. E.; MICHELSON, A. D.; FRELINGER, A. L.

Favourites:
ADD

Free Content The SLAM family member CD84 is regulated by ADAM10 and calpain in platelets
pp. 2581-2592(12)
Authors: HOFMANN, S.; VÖGTLE, T.; BENDER, M.; ROSE‐JOHN, S.; NIESWANDT, B.

Favourites:
ADD

Free Content Comparison of disseminated intravascular coagulation in trauma with coagulopathy of trauma/acute coagulopathy of trauma‐shock
pp. 2593-2595(3)
Authors: GANDO, S.; WADA, H.; KIM, H. K.; KUROSAWA, S.; NIELSEN, J. D.; THACHIL, J.; TOH, C.‐H.; Scientific and Standardization Committee on DIC of the ISTHcr8

Favourites:
ADD

Free Content Recommendations for measuring health‐related quality of life in children on anticoagulation
pp. 2596-2598(3)
Authors: BRUCE, A. K.; BAUMAN, M. E.; JONES, S.; MASSICOTTE, M. P.; MONAGLE, P.

Favourites:
ADD

Free Content Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis
pp. 2599-2601(3)
Authors: CARRIER, M.; KHORANA, A. A.; ZWICKER, J. I.; LYMAN, G. H.; LE GAL, G.; LEE, A. Y. Y.; on behalf of the subcommittee on Haemostasis and Malignancy for the SSC of the ISTHcr7

Favourites:
ADD

Free Content Incidental venous thromboembolism in oncology patients
pp. 2602-2604(3)
Authors: KHORANA, A. A.; O’CONNELL, C.; AGNELLI, G.; LIEBMAN, H. A.; LEE, A. Y. Y.; On Behalf of the Subcommittee on Hemostasis and Malignancy of the SSC of the ISTHcr6

Favourites:
ADD

Free Content Outcome of patients with suspected lower limb symptomatic deep vein thrombosis and a normal ultrasound‐based initial diagnostic workup: a prospective study
pp. 2605-2606(2)
Authors: CAMPORESE, G.; BERNARDI, E.; SCARANO, L.; GHIRARDUZZI, A.; IMBERTI, D.; PRANDONI, P.; on behalf of the PALIST Study Groupcr7

Favourites:
ADD

Free Content Staphylococcal superantigen‐like protein 5 induces thrombotic and bleeding complications in vivo: inhibition by an anti‐SSL5 antibody and the glycan Bimosiamose
pp. 2607-2609(3)
Authors: ARMSTRONG, P. C. J.; HU, H.; RIVERA, J.; RIGBY, S.; CHEN, Y.‐C.; HOWDEN, B. P.; GARDINER, E.; PETER, K.

Favourites:
ADD

Free Content Long‐term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users
pp. 2610-2612(3)
Authors: VERHOEF, T. I.; REDEKOP, W. K.; HEGAZY, H.; DE BOER, A.; MAITLAND‐van der ZEE, A. H.; on behalf of the EU‐PACT groupcr6

Favourites:
ADD

Free Content Coagulation factor X Arg386 specifically affects activation by the intrinsic pathway: a novel patient mutation
pp. 2613-2615(3)
Authors: VANDEN HOEK, A. L.; TALBOT, K.; CARTER, I. S. R.; VICKARS, L.; CARTER, C. J.; JACKSON, S. C.; MacGILLIVRAY, R. T. A.; PRYZDIAL, E. L. G.

Favourites:
ADD

Free Content Platelet reactivity is not associated with recurrent cardiovascular events in men with a history of myocardial infarction: a cohort study
pp. 2616-2618(3)
Authors: BONTEN, T. N.; SNOEP, J. D.; ROEST, M.; ROSENDAAL, F. R.; VAN DER BOM, J. G.

Favourites:
ADD

Free Content The vitronectin‐binding domain of plasminogen activator inhibitor‐1 plays an important functional role in lipopolysaccharide‐induced lethality in mice
pp. 2618-2621(4)
Authors: NARASAKI, R.; XU, Z.; LIANG, Z.; FUNG, L. C. W.; DONAHUE, D.; CASTELLINO, F. J.; PLOPLIS, V. A.

Favourites:
ADD

Free Content Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?
pp. 2621-2624(4)
Authors: SPYROPOULOS, A. C.; GOLDENBERG, N. A.; KESSLER, C. M.; KITTELSON, J.; SCHULMAN, S.; TURPIE, A. G. G.; CUTLER, N. R.; HIATT, W. R.; HALPERIN, J. L.; for The Antithrombotic Trials Leadership and Steering Group (ATLAS)cr10

Favourites:
ADD

Free Content Congenital disorder of glycosylation (PMM2‐CDG) in a patient with antithrombin deficiency and severe thrombophilia
pp. 2625-2627(3)
Authors: DE LA MORENA‐BARRIO, M. E.; SEVIVAS, T. S.; MARTINEZ‐MARTINEZ, I.; MIÑANO, A.; VICENTE, V.; JAEKEN, J.; CORRAL, J.

Favourites:
ADD

Free Content The incidence of diabetes mellitus following pulmonary embolism: a retrospective cohort study
pp. 2628-2630(3)
Authors: SECHTERBERGER, M. K.; HUTTEN, B. A.; HERMANIDES, J.; COHN, D. M.; HOEKSTRA, J. B. L.; KAMPHUISEN, P. W.; DeVRIES, J. H.

Favourites:
ADD

Free Content The accuracy of D‐dimer testing in suspected pulmonary embolism varies with the Wells score
pp. 2630-2632(3)
Authors: van ES, J.; BEENEN, L. F. M.; GERDES, V. E. A.; MIDDELDORP, S.; DOUMA, R. A.; BOSSUYT, P. M. M.

Favourites:
ADD

Free Content Join ISTH
pp. 2633-2633(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more